Measuring testosterone and testosterone replacement therapy in men receiving androgen deprivation therapy for prostate cancer: A survey of UK uro ‐oncologists’ opinions and practice

ConclusionUro ‐oncologists in the UK do not generally measure testosterone as part of their patient management and they remain cautious about the possible benefits of TRT in men with prostate cancer.This article is protected by copyright. All rights reserved.

Source: International Journal of Clinical Practice - November 10, 2018 Category: Internal Medicine Authors: Heather Payne, Rhona McMenemin, Amit Bahl, Damian Greene, John Staffurth Tags: Original Paper Source Type: research